Lilly’s Oral GLP-1, Orforglipron, Succeeds in Third Phase 3 Trial, Paving Way for Global Obesity Filings Read more
Johnson & Johnson Invests $2B in New State-of-the-Art Manufacturing Facility in North Carolina Read more
Andelyn Biosciences and Amplo Biotech Partner to Advance Gene Therapies for Neuromuscular Junction Disorders Read more
DAWNZERA (donidalorsen) Becomes First FDA-Approved RNA-Targeted Prophylactic for Hereditary Angioedema Read more
FDA Grants Orphan Drug Designation to Crinetics’ Atumelnant for Congenital Adrenal Hyperplasia Read more